Valuation : Stryker Corporation

Market Cap 124B 2,097B 106B 99.3B 90.92B 171B 11,801B 172B 1,176B 460B 5,947B 464B 454B 19,684B P/E 2026 *
25x
P/E 2027 * 21.8x
Enterprise Value 133B 2,252B 114B 107B 97.64B 184B 12,672B 184B 1,263B 494B 6,387B 498B 487B 21,137B EV / Sales 2026 *
4.86x
EV / Sales 2027 * 4.36x
Free-Float
94.9%
Yield 2026 *
1.12%
Yield 2027 * 1.19%
1 day-0.48%
1 week-0.48%
Current month+1.90%
1 month+0.45%
3 months+4.37%
6 months-10.44%
Current year-9.62%
1 month 5,567
Extreme 5567
5,879.57
Current year 5,025
Extreme 5025
6,769.22
1 year 5,025
Extreme 5025
7,293.22
3 years 4,663.01
Extreme 4663.01
8,216
5 years 3,953.6
Extreme 3953.6
8,216
10 years 2,469
Extreme 2469
8,216
Manager TitleAgeSince
Chief Executive Officer 60 2012-09-30
Director of Finance/CFO 50 2025-03-31
President 49 2025-12-31
Director TitleAgeSince
Director/Board Member 82 1973-12-31
Director/Board Member 71 1983-12-31
Chairman 60 2014-07-21
Change 5-day change 1-year change 3-year change Capi.($)
-0.48%-0.48% - - 126B
-2.29%-1.70%-18.07%+15.82% 126B
+0.14%+0.37%-22.28%-0.05% 12.24B
+0.74%-1.61%+91.24%+146.22% 10.65B
+2.13%-4.21%-51.63%-68.92% 4.21B
+0.57%+4.02%-22.01%+58.76% 2.77B
-1.59%-0.73%-34.11%-71.78% 1.79B
+1.12%-0.84%-23.32%-12.99% 1.66B
+0.47%-3.59%-36.96%-38.68% 1.59B
Average +0.09%-0.17%-14.64%+3.55% 20.17B
Weighted average by Cap. -1.15%-1.41%-12.53%+19.95%

Financials

2026 *2027 *
Net sales 27.3B 463B 23.43B 21.94B 20.09B 37.84B 2,607B 37.95B 260B 102B 1,314B 102B 100B 4,348B 29.67B 504B 25.47B 23.85B 21.84B 41.14B 2,834B 41.25B 282B 110B 1,428B 111B 109B 4,727B
Net income 4.94B 83.88B 4.24B 3.97B 3.64B 6.85B 472B 6.87B 47.03B 18.38B 238B 18.55B 18.15B 787B 5.75B 97.54B 4.93B 4.62B 4.23B 7.97B 549B 7.99B 54.68B 21.38B 277B 21.57B 21.11B 915B
Net Debt 9.13B 155B 7.83B 7.33B 6.72B 12.65B 872B 12.69B 86.84B 33.95B 439B 34.26B 33.52B 1,454B 5.89B 99.95B 5.05B 4.73B 4.33B 8.16B 562B 8.19B 56.03B 21.9B 283B 22.11B 21.63B 938B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
26-08-27 MX$5,504.00 -4.85% 305
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
322.12USD
Average target price
382.72USD
Spread / Average Target
+18.81%

Quarterly revenue - Rate of surprise